[October 13, 2015]

Stryker Spine to Feature Expanding Portfolio of Procedural Solutions at the North American Spine Society Meeting

The Spine Division of Stryker Corporation announced today that it will feature its expanding suite of procedural solutions for spinal surgery, including 10 new products launched in the first half of 2015, during the North American Spine Society (NASS) 30^th annual meeting in Chicago, October 14-17 (booth #1123).

Stryker Spine offers one of the most comprehensive and diverse product portfolios for the treatment of degenerative and complex spinal disorders. The Company is committed to pioneering innovative technologies for traditional and minimally invasive surgical techniques. Its suite of leading-edge products includes implants, instruments, and biologics for the cervical, thoracic, and lumbar spine.

"This is an exciting time for Stryker Spine," said Brad Paddock, President of Stryker Spine. "Our expanding portfolio of spinal procedural innovations and differentiated technology demonstrate our accelerated commitment to bringing state-of-the-art technology to physicians and their patients. Surgeons in increasing numbers are choosing Stryker Spine technologies. We will continue to expand and strengthen our leadership position in this segment and are thrilled to showcase our 10 new additions at this industry meeting. We believe these new offerings prove our continued commitment to our customers and future customers."

Newly launched products, based on advances in access, instrumentation, interbody, fixation, and biologics, include:

• Key additions to the LITe (Less Invasive Tecnologies) platform designed to provide a less invasive approach to spinal procedures, including the Decompression System and Anterior and Midline Retractors, as well as the Plate System (anterior and lateral), which provides a slim, low-profile fixation component to the LITe platform.
• Aero-LL, a lateral lumbar interbody and fixation system for use with autogenous bone graft in patients with degenerative disc disease.
• Tempus, an anterior cervical plating system featuring a secondary locking mechanism offering visual and tactile confirmation, large graft windows, and a low-profile design.
• New offerings in the biologics portfolio, including BIO⁴, a next-generation viable bone matrix; BIO DBM (demineralized bone matrix) available in Gel Putty and Plus; BIO AVS (News - Alert) AL for anterior lumbar interbody fusion procedures; and BIOExpand Demineralized Cancellous Sponge.

According to a recent MarketsandMarkets report, the global spinal implant and devices market will hit $15.73 billion by 2020, growing at a compound annual growth rate of 5.6 percent from 2015 to 2020. A number of factors are fueling the growth of the market, including the rising incidence and prevalence of spinal disorders; development of technologically advanced, safer, and more cost-effective spinal devices; the aging of the global population; the rise in obesity; and a rising demand for minimally invasive spine surgery, the report said.

About Stryker

Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world. Please contact us for more information at www.stryker.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151013005387/en/

[ Back To TMCnet.com's Homepage ]